The immunosuppressant drugs market in China is expected to reach a projected revenue of US$ 9,785.3 million by 2027. A compound annual growth rate of 9.6% is expected of China immunosuppressant drugs market from 2021 to 2027.
In terms of revenue, China accounted for 5.4% of the global immunosuppressant drugs market in 2020.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2027.
In Asia Pacific, China immunosuppressant drugs market is projected to lead the regional market in terms of revenue in 2027.
China is the fastest growing regional market in Asia Pacific and is projected to reach USD 9,785.3 million by 2027.
China is considered one of the favorable emerging markets around the world, mainly because of its large population base, low cost of manufacturing and strong R&D in the country. China’s population is ageing and, like many countries, the major disease burden is chronic illnesses. Chinese contemporary culture greatly values the importance of physical appearance of women and lays strong emphasis on ideal beauty standards.
Therefore, the country has become a hub for cosmetic dentistry procedures, and the major factor driving this market is increasing workplace competition. According to recently released data obtained from the 4th National Oral Health Epidemiology Survey, dental caries and periodontal disease are still major diseases that affect the oral health of Chinese people.
The prevalence of caries was above 50% in all age groups. Moreover dental tourism has increased in China, as Americans travel to the country for treatment because of availability of advanced technology, high quality of services, and shorter waiting period for most procedures, as well as ample availability of trained personnel. According to Ipsos, about 33 % people from China reported that they visited or consulted with a dentist or dental surgeon once a year and 18% visited twice a year.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Immunosuppressant Drugs Market will help companies and investors design strategic landscapes.
Monoclonal Antibodies was the largest segment with a revenue share of 73.48% in 2020.
Horizon Databook has segmented the China immunosuppressant drugs market based on calcineurin inhibitors, mtor inhibitors, antiproliferative agents, monoclonal antibodies covering the revenue growth of each sub-segment from 2016 to 2027.
China is considered one of the favorable emerging markets around the world, mainly because of its large population base, low cost of manufacturing and strong R&D in the country. China’s population is ageing and, like many countries, the major disease burden is chronic illnesses. Chinese contemporary culture greatly values the importance of physical appearance of women and lays strong emphasis on ideal beauty standards.
Therefore, the country has become a hub for cosmetic dentistry procedures, and the major factor driving this market is increasing workplace competition. According to recently released data obtained from the 4th National Oral Health Epidemiology Survey, dental caries and periodontal disease are still major diseases that affect the oral health of Chinese people.
The prevalence of caries was above 50% in all age groups. Moreover dental tourism has increased in China, as Americans travel to the country for treatment because of availability of advanced technology, high quality of services, and shorter waiting period for most procedures, as well as ample availability of trained personnel. According to Ipsos, about 33 % people from China reported that they visited or consulted with a dentist or dental surgeon once a year and 18% visited twice a year.
China Immunosuppressant Drugs Market Drug Class Outlook (Revenue, USD Million , 2016-2027)
Calcineurin Inhibitors
mTOR Inhibitors
Antiproliferative Agents
Monoclonal Antibodies
Others
China Immunosuppressant Drugs Market Application Outlook (Revenue, USD Million , 2016-2027)
Autoimmune Diseases
Organ Transplants
Other Applications
China Immunosuppressant Drugs Market Route of Administration Outlook (Revenue, USD Million , 2016-2027)
Oral
Injectables
China Immunosuppressant Drugs Market Distribution Channel Outlook (Revenue, USD Million , 2016-2027)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Reasons to subscribe to Immunosuppressant Drugs Market databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Immunosuppressant Drugs Market databook
Our clientele includes a mix of Immunosuppressant Drugs Market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China Immunosuppressant Drugs Market, including forecasts for subscribers. This country databook contains high-level insights into China Immunosuppressant Drugs Market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
China Immunosuppressant Drugs Market, 2016-2027 (US$M)